In a recent article, we discussed how courts have used patent specifications in finding that patents satisfy the Supreme Court’s Mayo/Alice test. However, the specification may be a double-edged sword ...

The Federal Circuit Court of Appeals affirmed the Patent Trial and Appeal Board's determination that a patent specification did not provide written description support for range limitations in the ...

In a recent series of cases, the Court of Appeals for the Federal Circuit (CAFC) evaluated whether examples in a patent specification will support infringement of alternative embodiments. Two recent ...

EDITOR’S NOTE: This article is an excerpt from Rules of Patent Drafting: Guidance from Federal Circuit Cases, 2014 Edition, which is now available at Amazon.com. This is the second installment of what ...

Early this spring, in Hoffmann-La Roche, Inc. v. Promega, the United States Court of Appeals for the Federal Circuit reviewed a district court opinion on the validity of an issued patent 1. The court ...

Guoquan Yang and Shuhui Huang of CCPIT explain how a ruling from the Supreme People’s Court over an Eli Lilly patent should determine the specificity of experiments described in patent applications ...

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

The scope and content of the patent specification is likely to determine the level of protection afforded EST and SNP inventions. Today, molecular biologists possess the tools to clone, sequence and ...

Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision. Lee (Harness IP): This is actually a huge-stakes case because this case discusses one of the most ...

A med tech case decided by the PTAB is helpful to inform patent strategy for AI enabled inventions across various disciplines and industries. Patent applicants should expect to see reliance by the ...

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP. Recently, all eyes have ...